Wu MF - Search Results

1

Endoglin as a predictive biomarker for pemetrexed sensitivity in non-small-cell lung cancer: a cellular study.

Cheng CY, Chuang WC, Lin CP, Li CH, Chang HY, Wu WJ, Wu MF, Ko JL. Cheng CY, et al. Among authors: wu mf. Cancer Chemother Pharmacol. 2025 Jan 10;95(1):20. doi: 10.1007/s00280-024-04734-9. Cancer Chemother Pharmacol. 2025. PMID: 39792181

2

Genetic determinants of pemetrexed responsiveness and nonresponsiveness in non-small cell lung cancer cells.

Wu MF, Hsiao YM, Huang CF, Huang YH, Yang WJ, Chan HW, Chang JT, Ko JL. Wu MF, et al. J Thorac Oncol. 2010 Aug;5(8):1143-51. doi: 10.1097/JTO.0b013e3181e0b954. J Thorac Oncol. 2010. PMID: 20559153 Free article.

3

Epigenetic mechanisms for silencing glutathione S-transferase m2 expression by hypermethylated specificity protein 1 binding in lung cancer.

Tang SC, Wu MF, Wong RH, Liu YF, Tang LC, Lai CH, Hsu CP, Ko JL. Tang SC, et al. Among authors: wu mf. Cancer. 2011 Jul 15;117(14):3209-21. doi: 10.1002/cncr.25875. Epub 2011 Jan 18. Cancer. 2011. PMID: 21246532 Free article.

4

Regulation of chemosensitivity and migration by clusterin in non-small cell lung cancer cells.

Cheng CY, Cherng SH, Wu WJ, Yang TY, Huang XY, Liao FT, Wu MF, Sheu GT. Cheng CY, et al. Among authors: wu wj, wu mf. Cancer Chemother Pharmacol. 2012 Jan;69(1):145-54. doi: 10.1007/s00280-011-1682-0. Epub 2011 Jun 1. Cancer Chemother Pharmacol. 2012. PMID: 21630085

5

Plasma Endoglin is Associated with Favorable Outcome for Pemetrexed-Based Therapy in Advanced Non-Small Cell Lung Cancer.

Li CH, Ko JL, Hsiao YP, Tsai MH, Lai YC, Hsin IL, Kang YT, Sheu GT, Lin WL, Wu MF. Li CH, et al. Among authors: wu mf. Cancer Manag Res. 2021 Dec 22;13:9305-9318. doi: 10.2147/CMAR.S338957. eCollection 2021. Cancer Manag Res. 2021. PMID: 35221721 Free PMC article.

6

Nuclear translocation of telomerase reverse transcriptase and calcium signaling in repression of telomerase activity in human lung cancer cells by fungal immunomodulatory protein from Ganoderma tsugae.

Liao CH, Hsiao YM, Sheu GT, Chang JT, Wang PH, Wu MF, Shieh GJ, Hsu CP, Ko JL. Liao CH, et al. Among authors: wu mf. Biochem Pharmacol. 2007 Nov 15;74(10):1541-54. doi: 10.1016/j.bcp.2007.07.025. Epub 2007 Jul 22. Biochem Pharmacol. 2007. PMID: 17720143

7

The mechanisms of action of Tianhua(™) on antitumor activity in lung cancer cells.

Li CT, Lin CH, Kao TY, Wu MF, Yeh CS, Yeh KT, Ko JL. Li CT, et al. Among authors: wu mf. Pharm Biol. 2010 Nov;48(11):1302-9. doi: 10.3109/13880201003789432. Epub 2010 Aug 25. Pharm Biol. 2010. PMID: 20738166 Free article.

8

GMI, an immunomodulatory protein from Ganoderma microsporum, induces autophagy in non-small cell lung cancer cells.

Hsin IL, Ou CC, Wu TC, Jan MS, Wu MF, Chiu LY, Lue KH, Ko JL. Hsin IL, et al. Among authors: wu tc, wu mf. Autophagy. 2011 Aug;7(8):873-82. doi: 10.4161/auto.7.8.15698. Epub 2011 Aug 1. Autophagy. 2011. PMID: 21490426

9

Lipocalin 2, a new GADD153 target gene, as an apoptosis inducer of endoplasmic reticulum stress in lung cancer cells.

Hsin IL, Hsiao YC, Wu MF, Jan MS, Tang SC, Lin YW, Hsu CP, Ko JL. Hsin IL, et al. Among authors: wu mf. Toxicol Appl Pharmacol. 2012 Sep 15;263(3):330-7. doi: 10.1016/j.taap.2012.07.005. Epub 2012 Jul 16. Toxicol Appl Pharmacol. 2012. PMID: 22800509

10

Reply to: Clusterin inhibition to enhance tumor chemosensitivity in systemic tumors.

Cheng CY, Cherng SH, Wu WJ, Yang TY, Huang XY, Liao FT, Wu MF, Sheu GT. Cheng CY, et al. Among authors: wu wj, wu mf. Cancer Chemother Pharmacol. 2013 Apr;71(4):1103-4. doi: 10.1007/s00280-013-2085-1. Cancer Chemother Pharmacol. 2013. PMID: 23377309 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

552 results

Search Page

Filters